Galecto, Inc. (GLTO) Dividend History

Galecto, Inc. (GLTO) is a biotechnology company focused on developing and commercializing treatments for fibrosis and cancer. It specializes in small molecule therapeutics targeting galectin proteins, which play a role in various pathological processes. The company's therapies aim to address unmet medical needs in diseases characterized by fibrosis and tumor progression.

75 State Street, Boston, MA, 02109
Phone: 45-70-70-52-10
Website: https://www.galecto.com

Dividend History

Galecto, Inc. currently does not pay dividends

Company News

Page data last updated 07/23/2025 14:47:40 UTC